Novel Therapy for Alzheimer Disease Agitation Gets Breakthrough Designation
The FDA has granted Breakthrough Therapy designation to AXS-05 (Axsome Therapeutics) for the treatment of Alzheimer disease (AD) agitation.
Alzheimer Disease
Healthy Lifestyle May Lower Risk for Alzheimer Dementia
A healthy lifestyle is associated with a reduced risk for Alzheimer dementia.
Antiepileptic Drugs May Increase Death Risk in Patients With Alzheimer Disease
Mortality risk in patients with AD was highest during the first three months of treatment with antiepileptic drugs.
First Diagnostic Agent Approved to Image Tau Pathology in Patients Being Evaluated for Alzheimer Disease
Tauvid is indicated for use with positron emission tomography (PET) imaging of the brain.
P-tau181 Biomarker Predicts Risk of Alzheimer Dementia
Plasma phosphorylated tau181 (P-tau181) may aid in the diagnosis of Alzheimer disease (AD), a study in Natural Medicine suggests.
Dementia Common in Down Syndrome Patients Aged ≥55
More than half of individuals with Down syndrome aged 55 years or older have dementia claims and 32.7% have Alzheimer disease (AD) claims.
Anemia and Abnormal Levels of Hemoglobin Correlated With Dementia, Alzheimer Disease
Low and high hemoglobin levels were associated with increased risk for dementia, white matter hyperintensity volume, and structural connectivity.
Can Pupillary Response in Cognitive Tasks Predict the Onset of Alzheimer Disease?
Pupillary dilation during cognitive tasks is associated with Alzheimer disease polygenic risk score.
Cerebrovascular Risk Factors May Increase Risk for Parkinson Disease
Most cerebrovascular risk factors are linked to a higher risk for subsequent diagnosis of Parkinson disease.
FDA Warns Companies to Stop Selling Dietary Supplements That Claim to Treat Alzheimer Disease
These products may prevent patients from seeking appropriate treatment.
-
Loading...
-
Loading...
